Departamento de Morfologia, Instituto de Ciências Biológicas (ICB), Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Departamento de Enfermagem Básica, Escola de Enfermagem da Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
Front Immunol. 2020 Jan 20;10:3120. doi: 10.3389/fimmu.2019.03120. eCollection 2019.
Joint pain is a distressing symptom of arthritis, and it is frequently persistent even after treatments which reduce local inflammation. Continuous production of algogenic factors activate/sensitize nociceptors in the joint structures and contribute to persistent pain, a challenging and difficult condition to treat. TNF is a crucial cytokine for the pathogenesis of several rheumatic diseases, and its inhibition is a mainstay of treatment to control joint symptoms, including pain. Here, we sought to investigate the inflammatory changes and the role of TNF in dorsal root ganglia (DRG) during persistent hypernociception after the resolution of acute joint inflammation. Using a model of antigen-induced arthritis, the peak of joint inflammation occurred 12-24 h after local antigen injection and was characterized by an intense influx of neutrophils, pro-inflammatory cytokine production, and joint damage. We found that inflammatory parameters in the joint returned to basal levels between 6 and 8 days after antigen-challenge, characterizing the resolving phase of joint inflammation. Mechanical hyperalgesia was persistent up to 14 days after joint insult. The persistent nociception was associated with the inflammatory status of DRG after cessation of acute joint inflammation. The late state of neuroinflammation in the ipsilateral side was evidenced by gene expression of TNF, TNFR2, IL-6, IL-1β, CXCL2, COX2, and iNOS in lumbar DRG (L3-L5) and leukocyte adhesion in the lumbar intumescent vessels between days 6 and 8. Moreover, there were signs of resident macrophage activation in DRG, as evidenced by an increase in Iba1-positive cells. Intrathecal or systemic injection of etanercept, an agent clinically utilized for TNF neutralization, at day 7 post arthritis induction, alleviated the persistent joint hyperalgesia by specific action in DRG. Our data suggest that neuroinflammation in DRG after the resolution of acute joint inflammation drives continuous neural sensitization resulting in persistent joint nociception in a TNF-dependent mechanism.
关节疼痛是关节炎的一种痛苦症状,即使在减轻局部炎症的治疗后,它也常常持续存在。持续产生的致痛因子会激活/敏化关节结构中的伤害感受器,导致持续性疼痛,这是一种具有挑战性且难以治疗的情况。TNF 是几种风湿性疾病发病机制中的关键细胞因子,其抑制是控制关节症状(包括疼痛)的主要治疗方法。在这里,我们试图研究在急性关节炎症消退后持续性高敏状态下,背根神经节(DRG)中的炎症变化和 TNF 的作用。使用抗原诱导的关节炎模型,局部抗原注射后 12-24 小时出现关节炎症峰值,其特征为大量中性粒细胞浸润、促炎细胞因子产生和关节损伤。我们发现,抗原挑战后 6-8 天,关节炎症的缓解阶段,关节中的炎症参数恢复到基础水平。机械性痛觉过敏可持续至关节损伤后 14 天。持续性疼痛与急性关节炎症停止后 DRG 的炎症状态有关。在同侧,腰椎 DRG(L3-L5)中 TNF、TNFR2、IL-6、IL-1β、CXCL2、COX2 和 iNOS 的基因表达以及腰椎膨出血管中的白细胞黏附,在第 6-8 天证明了神经炎症的晚期状态。此外,DRG 中存在驻留巨噬细胞活化的迹象,这表现为 Iba1 阳性细胞增加。在关节炎诱导后第 7 天鞘内或全身注射依那西普(一种临床上用于 TNF 中和的药物),通过 DRG 中的特异性作用缓解持续性关节痛觉过敏。我们的数据表明,急性关节炎症消退后 DRG 中的神经炎症导致持续的神经敏化,从而导致持续性关节疼痛,这是一种依赖 TNF 的机制。